Search research articles
Contact Us
Filters
Showing results (81-90 of 234) with videos related to
Page
of 24
Sort By:
Analytical Biochemistry
|
December 24, 2003
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry
Sharyn D Baker, Ming Zhao, Ping He, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2005
The potential of statins as part of anti-cancer treatment
Stefan Sleijfer, Ate van der Gaast, André S Th Planting, et al.
Cancer Letters
|
December 14, 2005
Role of pharmacogenetics in irinotecan therapy
Floris A de Jong, Maja J A de Jonge, Jaap Verweij, et al.
Pharmacogenomics
|
May 11, 2005
Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
Erin R Lepper, Kees Nooter, Jaap Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Modulation of irinotecan metabolism by ketoconazole
Diederik F S Kehrer, Ron H J Mathijssen, Jaap Verweij, et al.
Expert Opinion on Investigational Drugs
|
January 17, 2012
Danusertib, an aurora kinase inhibitor
Hielke J Meulenbeld, Ron Hj Mathijssen, Jaap Verweij, et al.
The Lancet. Oncology
|
October 4, 2015
Primary care in cancer control: towards mature cancer care
Carin A Uyl-de Groot, Werner B F Brouwer, Jan M de Maeseneer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 3, 2004
Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection
Erin R Lepper, J Kevin Hicks, Jaap Verweij, et al.
Anti-Cancer Drugs
|
December 1, 2005
Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion method
Frederike K Engels, Dirk Buijs, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development
George Poste, David P Carbone, David R Parkinson, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 234) with videos related to
Sort By:
Page
of 24
Analytical Biochemistry
|
December 24, 2003
Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry
Sharyn D Baker, Ming Zhao, Ping He, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2005
The potential of statins as part of anti-cancer treatment
Stefan Sleijfer, Ate van der Gaast, André S Th Planting, et al.
Cancer Letters
|
December 14, 2005
Role of pharmacogenetics in irinotecan therapy
Floris A de Jong, Maja J A de Jonge, Jaap Verweij, et al.
Pharmacogenomics
|
May 11, 2005
Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
Erin R Lepper, Kees Nooter, Jaap Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Modulation of irinotecan metabolism by ketoconazole
Diederik F S Kehrer, Ron H J Mathijssen, Jaap Verweij, et al.
Expert Opinion on Investigational Drugs
|
January 17, 2012
Danusertib, an aurora kinase inhibitor
Hielke J Meulenbeld, Ron Hj Mathijssen, Jaap Verweij, et al.
The Lancet. Oncology
|
October 4, 2015
Primary care in cancer control: towards mature cancer care
Carin A Uyl-de Groot, Werner B F Brouwer, Jan M de Maeseneer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 3, 2004
Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection
Erin R Lepper, J Kevin Hicks, Jaap Verweij, et al.
Anti-Cancer Drugs
|
December 1, 2005
Quantification of [3H]docetaxel in feces and urine: development and validation of a combustion method
Frederike K Engels, Dirk Buijs, Walter J Loos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2012
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development
George Poste, David P Carbone, David R Parkinson, et al.
Page
of 24